The European Medicines Agency (EMA) today assured that AstraZeneca's vaccine against covid-19 "is safe and effective", and is also not associated with cases of detected blood clots, which led to its discontinuation of use.
"The Pharmacovigilance Risk Assessment Committee has come to a clear conclusion in the investigation of blood clot cases: this is a safe and effective vaccine," said EMA Executive Director Emer Cooke, speaking at a press conference.
After an investigation in recent days by experts at the European regulator, Emer Cooke assured that the administration of AstraZeneca's vaccine "is not associated with an increased risk of thromboembolic events responsible for blood clots" in some of those vaccinated with this drug.
The position comes after in recent days several European countries, including Portugal, have decided as a precaution to suspend the administration of the AstraZeneca vaccine after reports of the appearance of blood clots and the death of people inoculated with this drug.
Comments